Table 1.
Variables | PAs-HSOS | BCS | P |
---|---|---|---|
Erythrocytes, 1012/L | 5.00 ± 4.33 | 4.33 ± 0.84 | 0.053 |
Hemoglobin, g/L | 135.99 ± 26.81 | 128.11 ± 24.00 | 0.061 |
Leukocyte, 109/L | 6.90 ± 2.81 | 4.87 ± 2.59 | <0.001 |
Platelet, 109/L | 114.06 ± 63.48 | 119.37 ± 83.98 | 0.651 |
ALT, U/L | 134.5 ± 154.89 | 40.60 ± 64.75 | 0.002 |
AST, U/L | 146.31 ± 156.30 | 49.72 ± 54.81 | 0.001 |
ALP, U/L | 170 ± 106.89 | 122.25 ± 69.08 | 0.003 |
γ-GT, U/L | 160.52 ± 114.56 | 106.60 ± 85.94 | 0.002 |
T-BIL, μmol/L | 65.07 ± 78.83 | 35.58 ± 28.47 | 0.001 |
Albumin, g/L | 30.71 ± 5.50 | 35.51 ± 6.29 | <0.001 |
PT, S | 17.43 ± 2.64 | 15.63 ± 2.01 | <0.001 |
Urea, mmol/L | 7.19 ± 3.63 | 5.26 ± 2.76 | 0.001 |
Cr, μmol/L | 90.65 ± 45.61 | 64.16 ± 18.67 | <0.001 |
Note: Baseline characteristics of PAs-induced HSOS refer to initial examination during first visit to our hospitals. PAs-HSOS PAs-induced HSOS; BCS Budd-Chiari syndrome; normal ranges: erythrocytes: 3.0–5.5 × 1012/L; hemoglobin: 110–160 g/L; leukocyte: 4–10 × 109 /L; platelet: 100–300 × 109/L; alanine aminotransferase: 5–35 U/L; aspartate aminotransferase (AST):8-40 U/L; alkaline phosphatase (ALP) 40–150 U/L; total bilirubin (T-BIL): 5.1–19 μmol/L; γ-glutamyl transpeptidase (γ-GT) 7–32 U/L; albumin: 35-55 g/L; prothrombin time (PT): 11–16 S; urea: 3.2–7.1 mmol/L; creatinine (Cr): 44–106 μmol/L.